SCHEMBL7913090

SCHEMBL7913090

O=[N+]([O-])c1cccc(-c2cccc(OCc3ccccc3)n2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.51
RAB9A P51151 4/20 0.51
CYP19A1 P11511 2/20 0.48
CYP11B1 P15538 2/20 0.48
CYP11B2 P19099 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
MAPT P10636 6/20 0.48
ALDH1A1 P00352 3/20 0.48
THRB P10828 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
TOP1 P11387 1/20 0.46
PDE4A P27815 1/20 0.46
PDE4C Q08493 1/20 0.46
PDE4D Q08499 1/20 0.46
CSNK2A1 P68400 1/20 0.46
GRM5 P41594 1/20 0.46
PLK1 P53350 1/20 0.46
KEAP1 Q14145 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20557346 0.79 MAPT (0.51) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL30469299 0.79 MAPT (0.51) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL15579478 0.75 MAOB (0.57) SMN1; SMN2MAPTALDH1A1THRBMEN1
SCHEMBL959834 0.74 L3MBTL1 (0.52) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL2965418 0.74 MAOB (0.63) RAB9AMAPTALDH1A1MEN1KMT2A
SCHEMBL30443578 0.74 MAOB (0.63) RAB9AMAPTALDH1A1MEN1KMT2A
SCHEMBL1385330 0.73 CYP19A1 (0.49) NPC1RAB9ACYP19A1CYP11B1CYP11B2
SCHEMBL14066782 0.73 PRMT5 (0.49) NPC1RAB9ACYP19A1CYP11B1CYP11B2
SCHEMBL25734395 0.73 POLB (0.55) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL9721944 0.72 LMNA (0.56) NPC1RAB9ASMN1; SMN2MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6211220-B1 ANTITUMOR AGENTS AND ANTICARCIINOGENIC AGENTS CELL PATHWAYS, INC. 2001-04-03 US disclosed
WO-1994029277-A1 AMILINO- OR PYRIDYLAMINO- CYCLOBUTENE- 1,2-DIONE DERIVATIVES AS cGMP PHOSPHODIESTERASE INHIBITORS SMITHKLINE BEECHAM PLC (GB) 1994-12-22 WO disclosed